-
Je něco špatně v tomto záznamu ?
In vitro antibacterial and antifungal activity of salicylanilide benzoates
Martin Krátký, Jarmila Vinšová, Vladimír Buchta
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS10367
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2000
PubMed Central
od 2000
Europe PubMed Central
od 2000
ProQuest Central
od 2012-01-01
Open Access Digital Library
od 2000-01-01 do 2012-01-02
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2012-01-03
Medline Complete (EBSCOhost)
od 2012-01-01
Health & Medicine (ProQuest)
od 2012-01-01
Wiley-Blackwell Open Access Titles
od 2000
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
22666101
DOI
10.1100/2012/290628
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky farmakologie MeSH
- antifungální látky farmakologie MeSH
- benzoáty farmakologie MeSH
- magnetická rezonanční spektroskopie MeSH
- mikrobiální testy citlivosti MeSH
- salicylanilidy farmakologie MeSH
- spektrofotometrie infračervená MeSH
- techniky in vitro MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The resistance to antimicrobial agents brings a need of novel antimicrobial agents. We have synthesized and found the in vitro antibacterial activity of salicylanilide esters with benzoic acid (2-(phenylcarbamoyl)phenyl benzoates) in micromolar range. They were evaluated in vitro for the activity against eight fungal and eight bacterial species. All derivatives showed a significant antibacterial activity against Gram-positive strains with minimum inhibitory concentrations ≥ 0.98 μmol/L including methicillin-resistant Staphylococcus aureus strain. The most active compounds were 5-chloro-2-(3,4-dichlorophenylcarbamoyl)phenyl benzoate and 4-chloro-2-(4-(trifluoromethyl)phenylcarbamoyl)phenyl benzoate. The antifungal activity is significantly lower.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13000753
- 003
- CZ-PrNML
- 005
- 20140905125606.0
- 007
- ta
- 008
- 130108s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1100/2012/290628 $2 doi
- 035 __
- $a (PubMed)22666101
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Krátký, Martin $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 245 10
- $a In vitro antibacterial and antifungal activity of salicylanilide benzoates / $c Martin Krátký, Jarmila Vinšová, Vladimír Buchta
- 520 9_
- $a The resistance to antimicrobial agents brings a need of novel antimicrobial agents. We have synthesized and found the in vitro antibacterial activity of salicylanilide esters with benzoic acid (2-(phenylcarbamoyl)phenyl benzoates) in micromolar range. They were evaluated in vitro for the activity against eight fungal and eight bacterial species. All derivatives showed a significant antibacterial activity against Gram-positive strains with minimum inhibitory concentrations ≥ 0.98 μmol/L including methicillin-resistant Staphylococcus aureus strain. The most active compounds were 5-chloro-2-(3,4-dichlorophenylcarbamoyl)phenyl benzoate and 4-chloro-2-(4-(trifluoromethyl)phenylcarbamoyl)phenyl benzoate. The antifungal activity is significantly lower.
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a antifungální látky $x farmakologie $7 D000935
- 650 _2
- $a benzoáty $x farmakologie $7 D001565
- 650 _2
- $a magnetická rezonanční spektroskopie $7 D009682
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a salicylanilidy $x farmakologie $7 D012458
- 650 _2
- $a spektrofotometrie infračervená $7 D013055
- 650 _2
- $a techniky in vitro $7 D066298
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vinšová, Jarmila $u Department of Inorganic and Organic Chemistry, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Buchta, Vladimír $u Department of Clinical Microbiology, Faculty of Medicine and University Hospital, Charles University, Hradec Králové, the Czech Republic; Department of Biological and Medical Sciences, Faculty of Pharmacy, Charles University, Hradec Králové, the Czech Republic
- 773 0_
- $w MED00181094 $t TheScientificWorldJournal $x 1537-744X $g Roč. 2012(2012), s. 290628
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22666101 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130108 $b ABA008
- 991 __
- $a 20140905130002 $b ABA008
- 999 __
- $a ok $b bmc $g 963535 $s 798917
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 2012 $d 290628 $i 1537-744X $m TheScientificWorldJournal $n ScientificWorldJournal $x MED00181094
- GRA __
- $a NS10367 $p MZ0
- LZP __
- $a Pubmed-20130108